Literature DB >> 36271282

Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study.

Sabina Galiniak1, Rafał Podgórski2, Marta Rachel2, Artur Mazur2.   

Abstract

The determination of hormonal biomarkers is of increasing interest in many diseases, including cystic fibrosis (CF). Hormones that have not been estimated and described so far in CF include kisspeptin (KISS) and proopiomelanocortin (POMC), which are involved in the regulation of many processes, including appetite and fertility. Therefore, the aim of our study was to estimate the level of KISS and POMC in sera from CF patients and to determine the correlation between these hormones and clinical parameters. For this purpose, we estimated the levels of KISS and POMC in 38 CF patients and 16 healthy participants with enzyme-linked immunosorbent assay. We found significantly reduced levels of KISS and POMC in people with CF compared to healthy subjects (1.76 ± 0.46 vs. 2.27 ± 0.56 ng/mL, p < 0.05 and 6.25 ± 4.36 vs. 14.74 ± 6.24 ng/mL, p < 0.001, respectively). Furthermore, the level of both hormones was negatively correlated with age. The hormones studied did not correlate with the results of spirometry and each other. Thus, decreased KISS and POMC levels may be associated with lower body weight and delayed puberty in patients with CF.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36271282     DOI: 10.1038/s41598-022-21851-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  38 in total

Review 1.  The Future of Biomarkers.

Authors:  Jean-Louis Vincent; Elisa Bogossian; Marco Menozzi
Journal:  Crit Care Clin       Date:  2020-01       Impact factor: 3.598

2.  Links between Disease Severity, Bacterial Infections and Oxidative Stress in Cystic Fibrosis.

Authors:  Sabina Galiniak; Mateusz Mołoń; Marta Rachel
Journal:  Antioxidants (Basel)       Date:  2022-04-29

3.  Circulating brain-derived neurotrophic factor, leptin, neuropeptide Y, and their clinical correlates in cystic fibrosis: a cross-sectional study.

Authors:  Jan K Nowak; Mariusz Szczepanik; Magdalena Trypuć; Andrzej Pogorzelski; Waldemar Bobkowski; Marcin Grytczuk; Alina Minarowska; Rafał Wójciak; Jaroslaw Walkowiak
Journal:  Arch Med Sci       Date:  2018-04-23       Impact factor: 3.318

Review 4.  Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy.

Authors:  Li Li; Shawn Somerset
Journal:  Dig Liver Dis       Date:  2014-07-19       Impact factor: 4.088

5.  Male reproductive health in cystic fibrosis.

Authors:  John C Yoon; Julio Leey Casella; Marina Litvin; Adrian S Dobs
Journal:  J Cyst Fibros       Date:  2019-10       Impact factor: 5.482

6.  Cystic Fibrosis-Related Diabetes in Poland.

Authors:  Marta Rachel; Marek Biesiadecki; Sabina Galiniak
Journal:  Int J Environ Res Public Health       Date:  2022-03-29       Impact factor: 3.390

Review 7.  Fertility and Pregnancy in Cystic Fibrosis.

Authors:  Michal Shteinberg; Jennifer L Taylor-Cousar; Isabelle Durieu; Malena Cohen-Cymberknoh
Journal:  Chest       Date:  2021-07-18       Impact factor: 9.410

8.  Managing Cystic Fibrosis in Polish Healthcare.

Authors:  Marta Rachel; Stanisław Topolewicz; Andrzej Śliwczyński; Sabina Galiniak
Journal:  Int J Environ Res Public Health       Date:  2020-10-20       Impact factor: 3.390

Review 9.  The Changing Landscape of Nutrition in Cystic Fibrosis: The Emergence of Overweight and Obesity.

Authors:  Julianna Bailey; Stefanie Krick; Kevin R Fontaine
Journal:  Nutrients       Date:  2022-03-13       Impact factor: 5.717

Review 10.  Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma.

Authors:  Heimo Breiteneder; Ya-Qi Peng; Ioana Agache; Zuzana Diamant; Thomas Eiwegger; Wytske J Fokkens; Claudia Traidl-Hoffmann; Kari Nadeau; Robyn E O'Hehir; Liam O'Mahony; Oliver Pfaar; Maria J Torres; De-Yun Wang; Luo Zhang; Cezmi A Akdis
Journal:  Allergy       Date:  2020-09-30       Impact factor: 14.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.